Ionis Pharmaceuticals (IONS) Exchange Rate Effect (2019 - 2026)
Ionis Pharmaceuticals' quarterly Exchange Rate Effect came in at -$138000.0 in Q1 2026, down 159.48% year-on-year from $232000.0 in Q1 2025, and down 220.93% quarter-over-quarter from -$43000.0 in Q4 2025.
Ionis Pharmaceuticals has reported Exchange Rate Effect for 8 years, with the latest figure at -$138000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 159.48% year-over-year to -$138000.0; the trailing twelve-month figure through Mar 2026 stood at $332000.0 (up 354.79% YoY), and the FY2025 full-year result was $702000.0, up 357.14% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$138000.0, down from -$43000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $595000.0 in Q2 2025, with the low at -$486000.0 in Q4 2024.
- Average Exchange Rate Effect over 5 years is $13235.3, with a median of -$43000.0 recorded in 2025.
- Year-over-year, Exchange Rate Effect slumped 1800.0% in 2022 and soared 2686.96% in 2025.
- Tracing IONS's Exchange Rate Effect over 5 years: stood at $546000.0 in 2022, then slumped by 39.56% to $330000.0 in 2023, then sank by 247.27% to -$486000.0 in 2024, then jumped by 91.15% to -$43000.0 in 2025, then plunged by 220.93% to -$138000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$138000.0 (Q1 2026), -$43000.0 (Q4 2025), and -$82000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.60 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -2.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -40.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -900,000.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -7.06 Mn |
| 10 | Ionis Pharmaceuticals | 12.61 Bn | 10.69 Bn | 243.11 Mn | -138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -138,000.00 |
| Mar 31, 2026 | -138,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Jun 30, 2025 | 595,000.00 |
| Jun 30, 2025 | 595,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Dec 31, 2024 | -486,000.00 |
| Dec 31, 2024 | -486,000.00 |
| Sep 30, 2024 | 350,000.00 |
| Sep 30, 2024 | 350,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Dec 31, 2023 | 330,000.00 |
| Dec 31, 2023 | 330,000.00 |
| Sep 30, 2023 | -152,000.00 |
| Sep 30, 2023 | -152,000.00 |
| Jun 30, 2023 | 70,000.00 |
| Jun 30, 2023 | 70,000.00 |
| Mar 31, 2023 | 104,000.00 |
| Mar 31, 2023 | 104,000.00 |
| Dec 31, 2022 | 546,000.00 |
| Dec 31, 2022 | 546,000.00 |
| Sep 30, 2022 | -399,000.00 |
| Sep 30, 2022 | -399,000.00 |
| Jun 30, 2022 | -411,000.00 |
| Jun 30, 2022 | -411,000.00 |
| Mar 31, 2022 | -154,000.00 |
| Mar 31, 2022 | -154,000.00 |
| Dec 31, 2021 | -68,000.00 |
| Dec 31, 2021 | -68,000.00 |
| Sep 30, 2021 | -21,000.00 |
| Sep 30, 2021 | -21,000.00 |
| Jun 30, 2021 | 104,000.00 |
| Jun 30, 2021 | 104,000.00 |
| Mar 31, 2021 | -126,000.00 |
| Mar 31, 2021 | -126,000.00 |
| Dec 31, 2020 | 259,000.00 |
| Dec 31, 2020 | 259,000.00 |
| Sep 30, 2020 | 276,000.00 |
| Sep 30, 2020 | 276,000.00 |
| Jun 30, 2020 | 74,000.00 |
| Jun 30, 2020 | 74,000.00 |
| Mar 31, 2020 | 8,000.00 |
| Mar 31, 2020 | 8,000.00 |
| Dec 31, 2019 | 93,000.00 |
| Dec 31, 2019 | 93,000.00 |